News
Welcome to the first issue of our quarterly newsletter. Subscribe now to receive these direct to your inbox.
Tim Cheeseright, CEO, reviews a year of significant growth for Torx® Software - from new additions to our global team to enhancements in our platform to streamline small molecule discovery chemistry.
Explore the typical tasks and challenges that chemists face every day, the traditional methods they use to manage, schedule and perform these tasks, and how Torx revolutionizes these processes, including:
Enable fluid sharing of molecules and results between computational and medicinal chemists by connecting Torx Design with Flare™.
Torx supports chemists across each stage of the Design-Make-Test-Analyze cycle by providing a central, secure location for information capture and sharing.
See where you can meet us at conferences and events in the coming months:
Cambridge, UK – 02 February 2023 – Torx® Software Limited, provider of the ground-breaking Torx technology platform for managing small ...
In this series, we've delved into the importance of collaboration and communication in drug discovery. Whether your project includes members ...
Every new small molecule drug starts with an idea. As significant time and resources are required to take a drug ...
